Department of Health and Social Care
Development of new antibiotics encouraged with new pharmaceutical payment system
The NHS will test the world's first ‘subscription’ style payment model to incentivise pharmaceutical companies to develop new drugs for resistant infections.
The new trial will be led by the National Institute for Health and Care Excellence (NICE) and NHS England and NHS Improvement.
It will test a ‘subscription’ style model that pays pharmaceutical companies upfront for access to drugs based on their usefulness to the NHS.
This will make it more attractive for companies to invest the estimated £1 billion it costs to develop a new drug, as they can be reassured they will still be paid for the drug even though it may be stored for reserves.
Currently, drugs companies are paid by volume of antibiotics sold, while the NHS is trying to reduce their use to prevent antimicrobial resistance (AMR).
Low returns on investment in development mean industry is reluctant to invest in the research and clinical trials necessary to bring new antibiotics to market.
NICE and NHS England and NHS Improvement are calling for companies to identify products to be considered for the initial phase of the test.
The work will be evaluated from the start and findings will be shared with the rest of the world so that other healthcare systems can test similar models.
Antibiotics have started to fail, with resistant bacteria already causing more than 700,000 deaths globally every year, making it vital that antibiotics are used only when needed.
Today’s announcements follows the government’s 2040 AMR vision and 5-year national action plan, published in January, and the appointment of Professor Dame Sally Davies as the first UK Special Envoy on AMR.
The latest phase of the ‘Keep Antibiotics Working Campaign’ will launch at the beginning of coughs and colds season this October to help reduce inappropriate use of antibiotics.
Health and Social Care Secretary, Matt Hancock, said:
There is no greater threat to global health than drug-resistant infections, yet there have been no major new antibiotic drug classes discovered since the 1980s.
Imagine a world in which a papercut can lead to infection that can’t be controlled. We must stop that from happening. Tackling superbugs needs global leadership and peoples’ lives depend on us finding a new way forward.
Our NHS is in a unique position to take a global lead in testing new payment models. We will take the lead but this is a global problem and we cannot succeed alone.
I am proud the UK is taking the first steps towards a solution and I am urging the rest of the world to join us in the fight against superbugs.
Health Minister Nicola Blackwood said:
Having a full pipeline of antimicrobials is critical in our efforts to address AMR, but currently not enough pharmaceutical companies are investing in the development of new drugs.
This project is an important step but it will only address global market failure if other countries do the same, which is why we want to involve as many countries as we can and share our learning from this work.
Today we are sending a strong signal to the rest of the world that there are workable models to stimulate investment in these vital medicines and that together we can tackle AMR.
Latest News from
Department of Health and Social Care
Building the best health system in the world18/06/2021 12:28:00
The Secretary of State for Health and Social Care Matt Hancock yesterday spoke at the virtual NHS Confed Conference.
Government sets out laws to validate accuracy of private COVID-19 tests18/06/2021 12:25:00
New draft legislation will make it easier for consumers to buy good quality COVID-19 tests with confidence.
Boxing stars champion COVID-19 vaccine as the 'best jab' of 202118/06/2021 10:10:10
Boxing legends star in a short film to encourage people to get COVID-19 vaccines.
Findings from COVID-19 round 12 REACT-1 study published18/06/2021 10:10:10
Findings from Imperial College London and Ipsos MORI show infections have increased by 50% since the last REACT-1 study in May, with 1 in 670 people infected.
Everyone working in care homes to be fully vaccinated under new law to protect residents17/06/2021 16:10:00
People working in CQC-registered care homes will need to be fully COVID-19 vaccinated with both doses.
More than 30 million people vaccinated with second dose17/06/2021 13:10:00
More than 30 million people in the UK have received a second dose of a COVID-19 vaccine, the latest figures published recently (15 June) show, as the vaccination programme continues at unprecedented pace and scale.
£36 million boost for AI technologies to revolutionise NHS care16/06/2021 16:30:00
Thirty-eight new pioneering artificial intelligence (AI) projects announced to help revolutionise care and accelerate diagnosis.
Care home residents can stay overnight as visiting restrictions ease15/06/2021 11:25:00
Care home residents will be able to spend more time with family and friends.